Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
Type:
Application
Filed:
July 27, 2022
Publication date:
December 22, 2022
Applicant:
CEVA SANTE ANIMALE S.A.
Inventors:
Jana SEELE, Christoph BAUMS, Peter VALENTIN-WEIGAND
Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rldeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
Type:
Application
Filed:
August 5, 2020
Publication date:
January 21, 2021
Applicant:
Ceva Santé Animale S.A.
Inventors:
Jana Seele, Christoph Baums, Peter Valentin-Weigand